Baxter Q4 sales $3.89B (+4%); full-year adj. EPS $2.60

BAXTER INTERNATIONAL INC

2023-FY EPS reported $5.25 revenue$14,813,000,000

Q4 sales from continuing ops $3.89B (+4% reported, +3% constant currency); GAAP EPS $0.14, adjusted EPS $0.88.
Full-year 2023 sales $14.81B (+2% reported, +3% constant currency); GAAP diluted loss ($0.15), adjusted EPS $2.60.
Company progressed on new operating model, sale of BioPharma Solutions, and planned Kidney Care separation.
CEO cited building momentum and improving macroeconomic/supply chain environment in 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BAXTER INTERNATIONAL INC reported the full year ended Dec. 31, 2023 results: revenue $14.81 billion, EPS ($0.15). Guidance initiated.

Period: the full year ended Dec. 31, 2023
Revenue: $14.81 billion
EPS: ($0.15)
Guidance: initiated
Result: reported results

Exact text from the filing

Full-year sales from continuing operations of $14.81 billion increased 2% on a reported basis and 3% on a constant currency basis • Full-year U.S. GAAP diluted EPS (loss) from continuing operations of ($0.15) and adjusted diluted EPS from continuing operations of $2.60

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BAXTER INTERNATIONAL INC reported the fourth quarter ended Dec. 31, 2023 results: revenue $3.89 billion, EPS $0.14. Guidance initiated.

Period: the fourth quarter ended Dec. 31, 2023
Revenue: $3.89 billion
EPS: $0.14
Guidance: initiated
Result: reported results

Exact text from the filing

Fourth-quarter sales from continuing operations of $3.89 billion increased 4% on a reported basis and 3% on a constant currency basis 1 • Fourth-quarter U.S. GAAP diluted earnings per share (EPS) from continuing operations of $0.14 and adjusted diluted EPS from continuing operations of $0.88

View on SEC.gov

Browse all earnings releases →

BAXTER INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001628280-24-003784

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.